Medical Food for Pancreatic Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a special diet that limits certain protein building blocks to help manage severe pancreatic cancer. It targets patients whose cancer cannot be surgically removed and who may not respond well to standard treatments. The diet aims to slow down or stop cancer growth by depriving it of essential nutrients.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants should be eligible for standard treatment with gemcitabine and nab-paclitaxel, which suggests that these medications may be part of the treatment plan.
How does NEAAR Medical Food differ from other treatments for pancreatic cancer?
What data supports the effectiveness of the treatment NEAAR Medical Food for pancreatic cancer?
Research suggests that nutritional interventions, like enteral nutrition and dietary supplements with omega-3 fatty acids, can help improve weight and reduce complications in pancreatic cancer patients. While NEAAR Medical Food is not directly studied, similar nutritional approaches have shown benefits in managing malnutrition and weight loss associated with pancreatic cancer.23678
Who Is on the Research Team?
Andrew Hendifar, MD
Principal Investigator
Cedars-Sinai
Are You a Good Fit for This Trial?
Adults with advanced or metastatic pancreatic adenocarcinoma who are starting standard chemotherapy (gemcitabine and nab-paclitaxel) can join. They must have measurable disease, good performance status, adequate organ function, and provide tissue samples. Excluded are those with severe weight issues, certain heart diseases or major surgeries recently, dietary restrictions on meat products, other cancer treatments within 6 months, brain metastasis or allergies to study drugs.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive NEAAR medical food along with gemcitabine and nab-paclitaxel for pancreatic cancer management
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- NEAAR Medical Food
Find a Clinic Near You
Who Is Running the Clinical Trial?
Faeth Therapeutics
Lead Sponsor